VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q59554981  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000208.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q59554981‏
024 ‎‡a  0000-0003-4125-224X‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q59554981‏
100 0 ‎‡a  Chi Huu Nguyen‏ ‎‡c  researcher ORCID ID = 0000-0003-4125-224X‏ ‎‡9  en‏
400 0 ‎‡a  Chi Huu Nguyen‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's 12(S)-HETE increases intracellular Ca(2+) in lymph-endothelial cells disrupting their barrier function in vitro; stabilization by clinical drugs impairing calcium supply‏
670 ‎‡a  Author's 12(S)-HETE induces lymph endothelial cell retraction in vitro by upregulation of SOX18‏
670 ‎‡a  Author's A eudesmane-type sesquiterpene isolated from Pluchea odorata (L.) Cass. combats three hallmarks of cancer cells: Unrestricted proliferation, escape from apoptosis and early metastatic outgrowth in vitro‏
670 ‎‡a  Author's AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12‏
670 ‎‡a  Author's AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12(S)-HETE synthesis‏
670 ‎‡a  Author's AIDS-associated Penicillium marneffei infection of the central nervous system‏
670 ‎‡a  Author's All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia‏
670 ‎‡a  Author's All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells‏
670 ‎‡a  Author's Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro.‏
670 ‎‡a  Author's Cancer cell-derived 12(S)-HETE signals via 12-HETE receptor, RHO, ROCK and MLC2 to induce lymph endothelial barrier breaching.‏
670 ‎‡a  Author's CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia‏
670 ‎‡a  Author's Chemical Composition of Scrophularia lucida and the Effects on Tumor Invasiveness in Vitro.‏
670 ‎‡a  Author's Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signalling‏
670 ‎‡a  Author's Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro‏
670 ‎‡a  Author's Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam.‏
670 ‎‡a  Author's Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells‏
670 ‎‡a  Author's Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model‏
670 ‎‡a  Author's IL2RA promotes aggressiveness and stem cell-related properties of acute myeloid leukemia‏
670 ‎‡a  Author's Intravasation of SW620 colon cancer cell spheroids through the blood endothelial barrier is inhibited by clinical drugs and flavonoids in vitro.‏
670 ‎‡a  Author's NF-κB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro.‏
670 ‎‡a  Author's SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness‏
670 ‎‡a  Author's THC‏
670 ‎‡a  Author's THC (Δ9-Tetrahydrocannabinol) Exerts Neuroprotective Effect in Glutamate-affected Murine Primary Mesencephalic Cultures Through Restoring Mitochondrial Membrane Potential and Anti-apoptosis Involving CB1 Receptor-dependent Mechanism‏
670 ‎‡a  Author's The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation‏
909 ‎‡a  (orcid) 000000034125224x‏ ‎‡9  1‏
919 ‎‡a  socs2ispartofahighlyprognostic4genesignatureinamlandpromotesdiseaseaggressiveness‏ ‎‡A  SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness‏ ‎‡9  1‏
919 ‎‡a  nfκbcontributestommp1expressioninbreastcancerspheroidscausingparacrinepar1activationanddisintegrationsinthelymphendothelialbarrierinvitro‏ ‎‡A  NF-κB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro.‏ ‎‡9  1‏
919 ‎‡a  intravasationofsw620coloncancercellspheroidsthroughthebloodendothelialbarrierisinhibitedbyclinicaldrugsandflavonoidsinvitro‏ ‎‡A  Intravasation of SW620 colon cancer cell spheroids through the blood endothelial barrier is inhibited by clinical drugs and flavonoids in vitro.‏ ‎‡9  1‏
919 ‎‡a  il2rapromotesaggressivenessandstemcellrelatedpropertiesofacutemyeloidleukemia‏ ‎‡A  IL2RA promotes aggressiveness and stem cell-related properties of acute myeloid leukemia‏ ‎‡9  1‏
919 ‎‡a  alltransretinoicacidinnonpromyelocyticacutemyeloidleukemiadriverlesiondependenteffectsonleukemicstemcells‏ ‎‡A  All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells‏ ‎‡9  1‏
919 ‎‡a  alltransretinoicacidenhancesandapanrarantagonistcounteractsthestemcellpromotingactivityofevi1inacutemyeloidleukemia‏ ‎‡A  All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia‏ ‎‡9  1‏
919 ‎‡a  aidsassociatedpenicilliummarneffeiinfectionofthecentralnervoussystem‏ ‎‡A  AIDS-associated Penicillium marneffei infection of the central nervous system‏ ‎‡9  1‏
919 ‎‡a  ahrcyp1a1interplaytriggerslymphaticbarrierbreachinginbreastcancerspheroidsbyinducing12shetesynthesis‏ ‎‡A  AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12(S)-HETE synthesis‏ ‎‡9  1‏
919 ‎‡a  ahrcyp1a1interplaytriggerslymphaticbarrierbreachinginbreastcancerspheroidsbyinducing12‏ ‎‡A  AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12‏ ‎‡9  1‏
919 ‎‡a  eudesmanetypesesquiterpeneisolatedfromplucheaodorata50casscombats3hallmarksofcancercellsunrestrictedproliferationescapefromapoptosisandearlymetastaticoutgrowthinvitro‏ ‎‡A  A eudesmane-type sesquiterpene isolated from Pluchea odorata (L.) Cass. combats three hallmarks of cancer cells: Unrestricted proliferation, escape from apoptosis and early metastatic outgrowth in vitro‏ ‎‡9  1‏
919 ‎‡a  12sheteinduceslymphendothelialcellretractioninvitrobyupregulationofsox18‏ ‎‡A  12(S)-HETE induces lymph endothelial cell retraction in vitro by upregulation of SOX18‏ ‎‡9  1‏
919 ‎‡a  fenofibrateinhibitstumourintravasationbyseveralindependentmechanismsina3dimensionalcoculturemodel‏ ‎‡A  Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model‏ ‎‡9  1‏
919 ‎‡a  evi1counteractsantileukemicandstemcellinhibitoryeffectsofalltransretinoicacidonflt3itdnpm1cdrivenacutemyeloidleukemiacells‏ ‎‡A  Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells‏ ‎‡9  1‏
919 ‎‡a  epidemiologyseasonalityandpredictorsofoutcomeofaidsassociatedpenicilliummarneffeiinfectioninhochiminhcityvietnam‏ ‎‡A  Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam.‏ ‎‡9  1‏
919 ‎‡a  colorectalcancercellderivedmicrorna200modulatestheresistanceofadjacentbloodendothelialbarriersinvitro‏ ‎‡A  Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro‏ ‎‡9  1‏
919 ‎‡a  coloncancercellderived12sheteinducestheretractionofcancerassociatedfibroblastviamlc2rhorockandca2+signalling‏ ‎‡A  Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signalling‏ ‎‡9  1‏
919 ‎‡a  chemicalcompositionofscrophularialucidaandtheeffectsontumorinvasivenessinvitro‏ ‎‡A  Chemical Composition of Scrophularia lucida and the Effects on Tumor Invasiveness in Vitro.‏ ‎‡9  1‏
919 ‎‡a  cgrpsignalingviacalcrlincreaseschemotherapyresistanceandstemcellpropertiesinacutemyeloidleukemia‏ ‎‡A  CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia‏ ‎‡9  1‏
919 ‎‡a  thcδ9tetrahydrocannabinolexertsneuroprotectiveeffectinglutamateaffectedmurineprimarymesencephalicculturesthroughrestoringmitochondrialmembranepotentialandantiapoptosisinvolvingcb1receptordependentmechanism‏ ‎‡A  THC (Δ9-Tetrahydrocannabinol) Exerts Neuroprotective Effect in Glutamate-affected Murine Primary Mesencephalic Cultures Through Restoring Mitochondrial Membrane Potential and Anti-apoptosis Involving CB1 Receptor-dependent Mechanism‏ ‎‡9  1‏
919 ‎‡a  germacranolidesesquiterpenelactoneneuroleninbofthemedicinalplantneurolaenalobata50rbrexcassinhibitsnpmalkdrivencellexpansionandnfκbdriventumourintravasation‏ ‎‡A  The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation‏ ‎‡9  1‏
919 ‎‡a  12sheteincreasesintracellularca2+inlymphendothelialcellsdisruptingtheirbarrierfunctioninvitrostabilizationbyclinicaldrugsimpairingcalciumsupply‏ ‎‡A  12(S)-HETE increases intracellular Ca(2+) in lymph-endothelial cells disrupting their barrier function in vitro; stabilization by clinical drugs impairing calcium supply‏ ‎‡9  1‏
919 ‎‡a  thc‏ ‎‡A  THC‏ ‎‡9  1‏
919 ‎‡a  cancercellderived12shetesignalsvia12hetereceptorrhorockandmlc2toinducelymphendothelialbarrierbreaching‏ ‎‡A  Cancer cell-derived 12(S)-HETE signals via 12-HETE receptor, RHO, ROCK and MLC2 to induce lymph endothelial barrier breaching.‏ ‎‡9  1‏
919 ‎‡a  apigeninandluteolinattenuatethebreachingofmdamb231breastcancerspheroidsthroughthelymphendothelialbarrierinvitro‏ ‎‡A  Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro.‏ ‎‡9  1‏
996 ‎‡2  SUDOC|166217573‏
996 ‎‡2  LC|no2016159699‏
996 ‎‡2  DNB|115225943‏
996 ‎‡2  NDL|033555286‏
996 ‎‡2  DNB|1313599344‏
996 ‎‡2  ISNI|0000000083758730‏
996 ‎‡2  NII|DA16141566‏
996 ‎‡2  ISNI|000000003593658X‏
996 ‎‡2  LC|nr 99039609‏
996 ‎‡2  DNB|123878799‏
996 ‎‡2  NUKAT|n 2014092479‏
996 ‎‡2  ISNI|0000000044669233‏
996 ‎‡2  ISNI|0000000036676943‏
996 ‎‡2  SUDOC|03241918X‏
996 ‎‡2  DNB|1181977207‏
996 ‎‡2  DNB|113707851‏
996 ‎‡2  ISNI|0000000384839956‏
996 ‎‡2  LC|n 2010209146‏
996 ‎‡2  ISNI|0000000086094052‏
996 ‎‡2  LC|nr 98018607‏
996 ‎‡2  DNB|132119188‏
996 ‎‡2  BNF|10532234‏
996 ‎‡2  LC|nr 99014400‏
996 ‎‡2  DNB|1047957280‏
996 ‎‡2  LC|n 84152400‏
996 ‎‡2  BNF|13536257‏
996 ‎‡2  LC|n 89612852‏
996 ‎‡2  CAOONL|ncf10237287‏
996 ‎‡2  ISNI|0000000432458251‏
996 ‎‡2  BNF|13557306‏
996 ‎‡2  ISNI|0000000370521306‏
996 ‎‡2  NDL|001346419‏
996 ‎‡2  SUDOC|19958608X‏
996 ‎‡2  ISNI|0000000029074696‏
996 ‎‡2  DNB|172678099‏
996 ‎‡2  SUDOC|176720421‏
996 ‎‡2  ISNI|0000000035725045‏
996 ‎‡2  ISNI|0000000076240298‏
996 ‎‡2  SUDOC|133379124‏
996 ‎‡2  LC|n 2012208352‏
996 ‎‡2  DNB|1143611845‏
996 ‎‡2  BNF|12837611‏
996 ‎‡2  LC|n 93102681‏
996 ‎‡2  LC|n 2016020695‏
996 ‎‡2  LC|no2006059916‏
996 ‎‡2  ISNI|0000000035405463‏
996 ‎‡2  DNB|1279662034‏
996 ‎‡2  SUDOC|104618442‏
996 ‎‡2  LC|n 2006221974‏
996 ‎‡2  DNB|142191426‏
996 ‎‡2  ISNI|0000000050041514‏
996 ‎‡2  LC|n 00047065‏
996 ‎‡2  ISNI|0000000139576056‏
996 ‎‡2  LC|n 2005014434‏
996 ‎‡2  ISNI|0000000432147226‏
996 ‎‡2  SUDOC|178093475‏
996 ‎‡2  LC|n 2020006437‏
996 ‎‡2  LC|no2017024761‏
996 ‎‡2  DNB|1281851590‏
996 ‎‡2  DNB|1158435215‏
996 ‎‡2  LC|nr 98010495‏
996 ‎‡2  BNF|12532432‏
996 ‎‡2  BNF|17777831‏
996 ‎‡2  DNB|1292780398‏
996 ‎‡2  SUDOC|270218513‏
996 ‎‡2  DNB|1198698551‏
996 ‎‡2  DNB|1217073442‏
996 ‎‡2  SUDOC|256850615‏
996 ‎‡2  SUDOC|12083989X‏
996 ‎‡2  LC|nr 98029561‏
996 ‎‡2  DNB|125539649‏
996 ‎‡2  DNB|1158062737‏
996 ‎‡2  DNB|115191391X‏
996 ‎‡2  DNB|1259476839‏
996 ‎‡2  DNB|1202561217‏
996 ‎‡2  LC|n 2010063876‏
996 ‎‡2  DNB|1328856747‏
996 ‎‡2  CAOONL|ncf10539797‏
996 ‎‡2  ISNI|0000000398992193‏
996 ‎‡2  ISNI|0000000033676307‏
996 ‎‡2  ISNI|0000000000598517‏
996 ‎‡2  SUDOC|165840285‏
996 ‎‡2  LC|no2010203354‏
996 ‎‡2  LC|n 84165433‏
996 ‎‡2  LC|no2006104413‏
996 ‎‡2  DNB|1158476825‏
996 ‎‡2  SUDOC|120237679‏
996 ‎‡2  SUDOC|166321613‏
996 ‎‡2  SUDOC|21990300X‏
996 ‎‡2  LC|n 2004034832‏
996 ‎‡2  DNB|1158478755‏
996 ‎‡2  LC|n 2021056565‏
996 ‎‡2  NKC|jo2009330725‏
996 ‎‡2  ISNI|0000000514463345‏
996 ‎‡2  BNF|14523490‏
996 ‎‡2  J9U|987007449791605171‏
996 ‎‡2  BNF|13069839‏
996 ‎‡2  SUDOC|154178926‏
996 ‎‡2  LC|nr 97039857‏
996 ‎‡2  ISNI|0000000118279378‏
996 ‎‡2  DNB|106817604‏
996 ‎‡2  PLWABN|9810676931405606‏
996 ‎‡2  PLWABN|9810613897805606‏
996 ‎‡2  LC|n 96058737‏
996 ‎‡2  SUDOC|233897046‏
996 ‎‡2  BNF|16531020‏
996 ‎‡2  NKC|xx0277187‏
996 ‎‡2  ISNI|0000000022369088‏
996 ‎‡2  J9U|987007351852405171‏
996 ‎‡2  ISNI|0000000067345928‏
996 ‎‡2  DNB|1260560481‏
996 ‎‡2  LC|n 97064338‏
996 ‎‡2  LC|no2024020238‏
996 ‎‡2  BNF|15539905‏
996 ‎‡2  SUDOC|113680333‏
996 ‎‡2  SUDOC|050662694‏
996 ‎‡2  BNF|12149521‏
996 ‎‡2  RERO|A026428000‏
996 ‎‡2  DNB|1081693320‏
996 ‎‡2  RERO|A018595292‏
996 ‎‡2  DNB|1068088168‏
996 ‎‡2  NSK|000650464‏
996 ‎‡2  SUDOC|12952154X‏
996 ‎‡2  ISNI|0000000014754840‏
996 ‎‡2  LC|n 2015246330‏
996 ‎‡2  NUKAT|n 2012055668‏
996 ‎‡2  NYNYRILM|45110‏
996 ‎‡2  BNF|14598899‏
996 ‎‡2  LC|n 2021044891‏
996 ‎‡2  BNF|15636434‏
996 ‎‡2  LC|n 84002404‏
996 ‎‡2  DNB|132472228‏
996 ‎‡2  ISNI|0000000451270780‏
996 ‎‡2  DNB|1112227563‏
996 ‎‡2  DNB|1044538953‏
996 ‎‡2  SUDOC|171036123‏
996 ‎‡2  ISNI|000000011803002X‏
996 ‎‡2  ISNI|0000000001946368‏
996 ‎‡2  NUKAT|n 2011123968‏
996 ‎‡2  ISNI|0000000024363931‏
996 ‎‡2  DNB|1247034070‏
996 ‎‡2  BIBSYS|90699859‏
996 ‎‡2  NII|DA16770175‏
996 ‎‡2  SUDOC|151165734‏
996 ‎‡2  DNB|13399581X‏
996 ‎‡2  PLWABN|9810676952005606‏
996 ‎‡2  LC|no2003097652‏
996 ‎‡2  SUDOC|029985897‏
996 ‎‡2  DNB|1159273030‏
996 ‎‡2  LC|n 2018071820‏
996 ‎‡2  ISNI|0000000008929413‏
996 ‎‡2  DNB|112046231‏
996 ‎‡2  ISNI|0000000036933401‏
996 ‎‡2  RERO|A014288809‏
996 ‎‡2  NII|DA1972978X‏
996 ‎‡2  ISNI|000000003375458X‏
996 ‎‡2  SUDOC|140846468‏
996 ‎‡2  SUDOC|203969480‏
996 ‎‡2  DNB|1317214730‏
996 ‎‡2  RERO|A027917004‏
996 ‎‡2  DNB|1025902238‏
996 ‎‡2  DNB|17190883X‏
996 ‎‡2  BNF|17808453‏
996 ‎‡2  DNB|123997984‏
996 ‎‡2  DNB|125027169X‏
996 ‎‡2  ISNI|0000000403310450‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏